JOB SUMMARY
We seek a motivated and scientifically curious Research Scientist I/II to join our Translational Biology team and contribute to the discovery and development of small-molecule cancer therapeutics, focusing on oncology. This position plays a critical role in integrating in vitro and in vivo pharmacology, external CRO coordination, and mechanistic/translational research to advance pipeline programs.
The candidate will work in a highly interdisciplinary environment alongside experts in machine learning, medicinal chemistry, analytical sciences, and computational biology, and will contribute both intellectually and experimentally to target mechanism validation, lead characterization, and translational biomarker strategy.
KEY RESPONSIBILITIES
Work closely with the Biology group/Project teams to design and develop translational studies for various programs
Design and manage in vivo pharmacology studies (PK/PD, efficacy, and toxicology with focus on oncology) at CROs
Coordinate biochemical and cell-based assay development and execution (in-house and externally) to support drug characterization and MOA studies
Design and execute hands-on experiments in cell and molecular biology, including:
Cell proliferation and viability assays
ELISA, Western blot, qPCR, flow cytometry
Reporter assays and proximity-based assays (e.g., AlphaLISA, HTRF, NanoBRET)
Work with cross-functional teams to QC and upload data in a timely, organized manner
Analyze and interpret data from internal experiments, CRO deliverables, and scientific literature to guide decision-making
Collaborate across functional teams to align experimental designs with project goals
Contribute to data curation, knowledge management, and infrastructure to support high-quality decision making
Conduct literature reviews to support the mechanism of action, mechanism of resistance, and translational biomarker strategies
Present experimental results and project updates at internal team meetings
REQUIREMENTS
PhD with 0-5 years of experience in biochemistry, cell biology, cancer biology, pharmacology, or related discipline
or MS with 5+ years / BS with 8+ years of relevant industry experience
Experience in cancer research, mechanism of action/resistance, or translational biomarker development is highly desirable
Hands-on experience in in vivo pharmacology, including:
Designing and interpreting PK/PD and efficacy studies in oncology models
Familiarity with dosing strategies, route of administration, and biomarker collection (e.g., plasma, tumor tissues)
Oversight and coordination of in vivo studies at CROs, with ability to review protocols, QC data, and troubleshoot issues
Strong proficiency in cell and molecular biology, including cell culture, cell engineering, ELISA, Western blotting, qPCR, and flow cytometry
Experience developing and troubleshooting biochemical and cell-based assays to evaluate small molecule compounds
Ability to independently design experiments and analyze data to guide drug discovery and development
Excellent communication skills and ability to work collaboratively across teams
Highly motivated to learn new technologies and contribute across multiple projects
ABOUT IAMBIC THERAPEUTICS
Founded in 2019 and headquartered in San Diego, California, Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform. Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters with strong track records of success in delivering clinically validated therapeutics. The Iambic platform has been demonstrated to deliver high-quality, differentiated therapeutics to clinical stage with unprecedented speed and across multiple target classes and mechanisms of action. The Iambic team is advancing an internal pipeline of clinical assets to address urgent unmet patient needs. Learn more about the Iambic team, platform, and pipeline at iambic.ai.
MISSION & CORE VALUES
The culture and work at Iambic Therapeutics are profoundly strengthened by the diversity of our people and our differences in background, culture, national origin, religion, sexual orientation, and life experiences. We are committed to building an inclusive environment where a diverse group of talented humans work together to discover therapeutics and create technologies.
ALSO
We offer industry leading competitive pay, company paid healthcare, flexible spending accounts, voluntary life Insurance, 401K matching, and unlimited vacation to our team. We are in a brand-new state-of-the art facility in beautiful San Diego with an onsite gym, dining, and easy access to great places to live and play.
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
Are you ready to dive into an exciting role as a Research Scientist I/II at Iambic Therapeutics? Located in sunny San Diego, this position offers the unique opportunity to engage in groundbreaking work focused on small-molecule cancer therapeutics within our Translational Biology team. As part of our mission to tackle challenging cancers, you'll play a vital role in the design and management of in vivo pharmacology studies, coordinating with external CROs to ensure the highest standards of efficacy and toxicity analysis. You'll work in an interdisciplinary environment alongside experts in machine learning, medicinal chemistry, and computational biology, contributing to target mechanism validation and lead characterization. This role is not just about conducting experiments; you'll collaborate closely with cross-functional teams, analyze data, manage projects, and share your findings. If you hold a PhD with 0-5 years of relevant experience or a Master’s degree with a more extensive background, along with a passion for cancer research and a hands-on approach to experiment design, you might be just the person we need. At Iambic Therapeutics, we foster a dynamic and inclusive culture, offering competitive pay, comprehensive benefits, and unlimited vacation. Are you ready to join us on this journey?
Subscribe to Rise newsletter